Establishing women's cancer care services in a fragile, conflict and violence affected ecosystem in Africa.
African cancer centre
Democratic Republic of the Congo
Dikembe Mutombo
breast cancer
cervical cancer
conflict and violence affected societies
fragile
Journal
Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
11
2020
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
epublish
Résumé
The majority of the world's poorest women (income < $1.90/day) reside in fragile, conflict and violence (FCV)-affected countries, like the Democratic Republic of the Congo. Health services in these settings have traditionally focused on immediate relief efforts, communicable diseases and malnutrition. Recent data suggests there is need to widen the focus to include cancer, as its incidence and mortality rates are rising. Employing competency-based learning strategies, Congolese health professionals were trained to perform same-day cervical cancer screening and treatment of precancerous lesions of the cervix; same-day clinical breast examination and breast ultrasound diagnostics; surgical treatment of invasive cancers of the breast and cervix; and infusion of cytotoxic chemotherapy. Outpatient breast and cervical cancer care clinics, a chemotherapy suite and surgical theatres were outfitted with equipment and supplies. Combining local and regional hands-on training seminars with wise infrastructure investments, a team of US and Zambian oncology experts successfully implemented a clinical service platform for women's cancers in a private sector health facility in the Democratic Republic of the Congo. We forged a novel partnership between oncology health professionals from Africa and its Diaspora, international philanthropic organisations, a cancer medicine access initiative and an established African cancer centre to build women's cancer services in a FVC-affected African setting.
Sections du résumé
BACKGROUND
BACKGROUND
The majority of the world's poorest women (income < $1.90/day) reside in fragile, conflict and violence (FCV)-affected countries, like the Democratic Republic of the Congo. Health services in these settings have traditionally focused on immediate relief efforts, communicable diseases and malnutrition. Recent data suggests there is need to widen the focus to include cancer, as its incidence and mortality rates are rising.
METHODS
METHODS
Employing competency-based learning strategies, Congolese health professionals were trained to perform same-day cervical cancer screening and treatment of precancerous lesions of the cervix; same-day clinical breast examination and breast ultrasound diagnostics; surgical treatment of invasive cancers of the breast and cervix; and infusion of cytotoxic chemotherapy. Outpatient breast and cervical cancer care clinics, a chemotherapy suite and surgical theatres were outfitted with equipment and supplies.
RESULTS
RESULTS
Combining local and regional hands-on training seminars with wise infrastructure investments, a team of US and Zambian oncology experts successfully implemented a clinical service platform for women's cancers in a private sector health facility in the Democratic Republic of the Congo.
CONCLUSION
CONCLUSIONS
We forged a novel partnership between oncology health professionals from Africa and its Diaspora, international philanthropic organisations, a cancer medicine access initiative and an established African cancer centre to build women's cancer services in a FVC-affected African setting.
Identifiants
pubmed: 34221114
doi: 10.3332/ecancer.2021.1231
pii: can-15-1231
pmc: PMC8225336
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1231Informations de copyright
© the authors; licensee ecancermedicalscience.
Déclaration de conflit d'intérêts
None of the authors declare any conflicts of interest.
Références
AIDS. 2009 Mar 27;23(6):N1-5
pubmed: 19279439
Br J Cancer. 2020 Jul;123(1):148-154
pubmed: 32336751
BMC Public Health. 2014 Jul 28;14:759
pubmed: 25070656
Lancet. 2018 Sep 22;392(10152):985
pubmed: 30264708
Glob Health Action. 2015 Jan 05;8:25480
pubmed: 25563450
JCO Glob Oncol. 2020 Jun;6:859-865
pubmed: 32579485
Arch Surg. 1988 Aug;123(8):972-4
pubmed: 2840053
Fam Pract. 1986 Jun;3(2):102-6
pubmed: 3721092
Lancet Oncol. 2013 Apr;14(4):e168-75
pubmed: 23561748
Lancet. 2010 Oct 2;376(9747):1186-93
pubmed: 20709386
Gynecol Oncol. 2011 Jan;120(1):3-4
pubmed: 21174370
Ecancermedicalscience. 2020 May 08;14:1039
pubmed: 32565892
BMC Med. 2020 Sep 10;18(1):266
pubmed: 32907570
Lancet. 2017 Feb 25;389(10071):847-860
pubmed: 27814965
PLoS One. 2018 May 10;13(5):e0196985
pubmed: 29746541
PLoS One. 2015 Apr 17;10(4):e0122169
pubmed: 25885821
Cancer. 2020 May 15;126 Suppl 10:2339-2352
pubmed: 32348573
Gynecol Oncol Rep. 2018 Oct 04;26:60-65
pubmed: 30364674
Breast. 2015 Oct;24(5):642-8
pubmed: 26279132
BMC Womens Health. 2014 Feb 18;14(1):30
pubmed: 24548698
Infect Agent Cancer. 2015 Jul 15;10:20
pubmed: 26180542
BMC Int Health Hum Rights. 2020 Jul 31;20(1):21
pubmed: 32736623
Ecancermedicalscience. 2019 Jul 25;13:953
pubmed: 31552126
Rural Remote Health. 2009 Jul-Sep;9(3):1131
pubmed: 19653801
Lancet Glob Health. 2019 Dec;7(12):e1622-e1631
pubmed: 31669039
Int J Cancer. 1992 Jan 2;50(1):45-8
pubmed: 1309459
J Glob Oncol. 2018 Sep;4:1-8
pubmed: 30241176
Gynecol Oncol. 2012 Feb;124(2):286-91
pubmed: 22062546
Oncologist. 2016 Jun;21(6):739-44
pubmed: 27091419
J Glob Oncol. 2016 Oct 12;3(5):635-657
pubmed: 29094101
Int J Cancer. 2006 Sep 15;119(6):1389-95
pubmed: 16619217
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Health Policy Plan. 2018 Feb 1;33(suppl_1):i1-i3
pubmed: 29415241